|
Jack Hirsh, professor emeritus in medicine and director of the Henderson
Research Centre.
Jack Hirsh
Dr. Jack Hirsh, professor emeritus in medicine and director of
the Henderson Research Centre, is an internationally recognized
clinician and scientist in anti-coagulant therapy and thrombosis.
His research group pioneered the discovery and development of low
molecular weight heparin, increased the safety and utility of warfarin
and heparin anticoagulants, helped to establish Aspirin in treating
heart attack and stroke, and developed objective diagnostic testing
for diagnosis of venous thrombosis.
|
 |
 |
A member of the Order of Canada, a recipient of the International
Gairdner Research Award, and a Fellow of the Royal Society
of Canada, Dr. Hirsh has developed a world-renowned program
for diagnosis, prevention and treatment of thrombosis (abnormal
blood clots) and atherosclerosis.
In 1988 Dr. Hirsh established the Hamilton Civic Hospitals
Research Centre. He is vice-president, research, of Hamilton
Health Sciences, and is vice-president, cardiovascular research,
of GlycoDesign, a publicly traded biopharmaceutical company
involved in discovery and development of drugs for treating
cardiovascular disease, inflammatory diseases, cancer and
infectious diseases.
“My advice to budding researchers is to be passionate
about your research, train with the best in your area of interest
and spend as long as it takes to develop the skills required
to be an independent researcher.”
<
BACK TO FACES
OF INNOVATION
|
|
